Chat with us, powered by LiveChat

Loading...

Bioinformatics Services Market Report

RA01340

Bioinformatics Services Market, by Type (Sequencing Services, Data Analysis, Drug Discovery Services, Differential Gene Expression Analysis, Database and Management Services, Other Bioinformatics Services), Specialty (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology), Application (Genomics, Chemoinformatics and Drug Design, Proteomics, Transcriptomics, Metabolomics, Other Applications), End User (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users): Global Opportunity Analysis and Industry Forecast, 2020-2027

RA01340

Pages: 150

Jan 2023

The global bioinformatics services market is estimated to surpass $6,218.5 million by 2027, exhibiting a CAGR of 15.5% from 2020 to 2027.

The report provides all-inclusive analysis of global bioinformatics services market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.

The report emphasizes current market scenario and future trends of the global bioinformatics services market which gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market. Besides, the report provides Porter’s five forces analysis which precisely underlines the impact of key forces on the global bioinformatics services market.

In addition, the report provides market size and forecast scrutinizing global bioinformatics services market through different segments. The report highlights the geographical market analysis of these segments and each segment is thoroughly studied at regional as well as country level to get clearer picture of the global bioinformatics services market. In the report, the global bioinformatics services market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover bioinformatics services market landscape in respective regions.

Furthermore, competitive scenario of the global bioinformatics services market is covered in the report. Major players functioning in the global bioinformatics services market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global bioinformatics services market, and others.

Research Methodology

Research Dive offers its clients extensive research and analysis gleaned from wide variety of factual inputs that largely includes interview with participants of the industry, reliable data & statistics, and regional intelligence. The in-house experts of the industry play a crucial role in designing analytic tools and models, tailor-made to the requests of an industry segment. The data and statistics are sterilized with these analytical tools and models, which enhances the accuracy of our advice and recommendations.

This research report is delivered by Research Dive by conducting long hours of discussions and interviews, with a broad range of stakeholders, which includes upstream and downstream participants. Our analysts have performed a mix of primary and secondary research for the market estimations and forecasts. A number of product type literatures, industry releases, annual reports, and other related documents of major participants of the industry have been reviewed, to better understand the global bioinformatics services market scenario. The initial phase of our in-depth study, where we perform wide-range data mining, referring to proficient & verified data sources such as independent studies, medical journals, technical journals, releases by trade association, materials published by government & regulatory authorities, and other.

KEY MARKET BENEFITS

  • This report is a compilation of detailed study, information, valid inputs from industry experts & industry participants across the value chain, and quantitative & qualitative assessment by analysts of the industry.
  • The report provides a comprehensive analysis along with the current trends of market during the forecast period from 2019 to 2027 to identify & comprehend the prevailing opportunities and the strategic assessment of the global bioinformatics services market growth.
  • The report studies the market from 2019 to 2027 and maps the qualitative impact of several industry factors on market segments as well as geographies.
  • The report provides market estimations and size which is based on in-depth analysis of recent & key developments in the bioinformatics services market.
  • The development strategies implemented by the key industry players are conscripted in the report to understand the competitive scenario of the global bioinformatics services market.

KEY MARKET SEGMENTS

The market has been studied based on the following segments:

  • Type: Sequencing Services, Data Analysis, Drug Discovery Services, Differential Gene Expression Analysis, Database and Management Services, Other Bioinformatics Services
  • Specialty: Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology
  • Application: Genomics, Chemoinformatics and Drug Design, Proteomics, Transcriptomics, Metabolomics, Other Applications
  • End User: Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users

Region:

The global bioinformatics services market is divided into North America, Europe, Asia Pacific, and LAMEA.

The above-mentioned regions are further dived in countries as follows:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of LAMEA

 

KEY MARKET PLAYERS

The report covers the major players operating in the global bioinformatics services market that focus on advancements & innovations and geographical expansion of product portfolios to obtain a competitive edge in the market space. The major players enlisted in the report include QIAGEN, Microsynth, PerkinElmer, Source BioScience, …., and others.

The report summarizes various aspects of all these key players that include as follows:

    1. Illumina

    2. Thermo Fisher Scientific

    3. Eurofins Scientific

    4. BGI

    5. NeoGenomics

    6. PerkinElmer

    7. CD Genomics

    8. Macrogen

    9. QIAGEN

    10. GENEWIZ

    11. Source BioScience

    12. Microsynth

    13. MedGenome

    14. Fios Genomics

    15. BaseClear

  • 1. RESEARCH METHODOLOGY

    • 1.1. Desk Research

    • 1.2. Real time insights and validation

    • 1.3. Forecast model

    • 1.4. Assumptions and forecast parameters

    • 1.5. Market size estimation

      • 1.5.1. Top-down approach

      • 1.5.2. Bottom-up approach

  • 2. REPORT SCOPE

    • 2.1. Market definition

    • 2.2. Key objectives of the study

    • 2.3. Report overview

    • 2.4. Market segmentation

    • 2.5. Overview of the impact of COVID-19 on Global Bioinformatics Services Market

  • 3. EXECUTIVE SUMMARY

  • 4. MARKET OVERVIEW

    • 4.1. Introduction

    • 4.2. Growth impact forces

      • 4.2.1. Drivers

      • 4.2.2. Restraints

      • 4.2.3. Opportunities

    • 4.3. Market value chain analysis

      • 4.3.1. List of raw material suppliers

      • 4.3.2. List of manufacturers

      • 4.3.3. List of distributors

    • 4.4. Innovation & sustainability matrices

      • 4.4.1. Technology matrix

      • 4.4.2. Regulatory matrix

    • 4.5. Porter’s five forces analysis

      • 4.5.1. Bargaining power of suppliers

      • 4.5.2. Bargaining power of consumers

      • 4.5.3. Threat of substitutes

      • 4.5.4. Threat of new entrants

      • 4.5.5. Competitive rivalry intensity

    • 4.6. PESTLE analysis

      • 4.6.1. Political

      • 4.6.2. Economical

      • 4.6.3. Social

      • 4.6.4. Technological

      • 4.6.5. Environmental

    • 4.7. Impact of COVID-19 on Bioinformatics Services Market

      • 4.7.1. Pre-covid market scenario

      • 4.7.2. Post-covid market scenario

  • 5. Bioinformatics Services Market, By Infections

    • 5.1. Overview

    • 5.2 Sequencing Services

      • 5.2.1 Definition, key trends, growth factors, and opportunities

      • 5.2.2 Market size analysis, by region, 2020-2027

      • 5.2.3 Market share analysis, by country, 2020-2027

    • 5.3 Data Analysis

      • 5.3.1 Definition, key trends, growth factors, and opportunities

      • 5.3.2 Market size analysis, by region, 2020-2027

      • 5.3.3 Market share analysis, by country, 2020-2027

    • 5.4 Drug Discovery Services

      • 5.4.1 Definition, key trends, growth factors, and opportunities

      • 5.4.2 Market size analysis, by region, 2020-2027

      • 5.4.3 Market share analysis, by country, 2020-2027

    • 5.5 Differential Gene Expression Analysis

      • 5.5.1 Definition, key trends, growth factors, and opportunities

      • 5.5.2 Market size analysis, by region, 2020-2027

      • 5.5.3 Market share analysis, by country, 2020-2027

    • 5.6 Database and Management Services

      • 5.6.1 Definition, key trends, growth factors, and opportunities

      • 5.6.2 Market size analysis, by region, 2020-2027

      • 5.6.3 Market share analysis, by country, 2020-2027

    • 5.7 Other Bioinformatics Services

      • 5.7.1 Definition, key trends, growth factors, and opportunities

      • 5.7.2 Market size analysis, by region, 2020-2027

      • 5.7.3 Market share analysis, by country, 2020-2027

    • 5.8 Research Dive Exclusive Insights

      • 5.8.1 Market attractiveness

      • 5.8.2 Competition heatmap

  • 6. Bioinformatics Services Market, By Testing Type

    • 6.1. Overview

    • 6.2 Medical Biotechnology

      • 6.2.1 Definition, key trends, growth factors, and opportunities

      • 6.2.2 Market size analysis, by region, 2020-2027

      • 6.2.3 Market share analysis, by country, 2020-2027

    • 6.3 Animal Biotechnology

      • 6.3.1 Definition, key trends, growth factors, and opportunities

      • 6.3.2 Market size analysis, by region, 2020-2027

      • 6.3.3 Market share analysis, by country, 2020-2027

    • 6.4 Plant Biotechnology

      • 6.4.1 Definition, key trends, growth factors, and opportunities

      • 6.4.2 Market size analysis, by region, 2020-2027

      • 6.4.3 Market share analysis, by country, 2020-2027

    • 6.5 Environmental Biotechnology

      • 6.5.1 Definition, key trends, growth factors, and opportunities

      • 6.5.2 Market size analysis, by region, 2020-2027

      • 6.5.3 Market share analysis, by country, 2020-2027

    • 6.6 Forensic Biotechnology

      • 6.6.1 Definition, key trends, growth factors, and opportunities

      • 6.6.2 Market size analysis, by region, 2020-2027

      • 6.6.3 Market share analysis, by country, 2020-2027

    • 6.7 Research Dive Exclusive Insights

      • 6.7.1 Market attractiveness

      • 6.7.2 Competition heatmap

  • 7. Bioinformatics Services Market, By Resorbability

    • 7.1. Overview

    • 7.2 Genomics

      • 7.2.1 Definition, key trends, growth factors, and opportunities

      • 7.2.2 Market size analysis, by region, 2020-2027

      • 7.2.3 Market share analysis, by country, 2020-2027

    • 7.3 Chemoinformatics and Drug Design

      • 7.3.1 Definition, key trends, growth factors, and opportunities

      • 7.3.2 Market size analysis, by region, 2020-2027

      • 7.3.3 Market share analysis, by country, 2020-2027

    • 7.4 Proteomics

      • 7.4.1 Definition, key trends, growth factors, and opportunities

      • 7.4.2 Market size analysis, by region, 2020-2027

      • 7.4.3 Market share analysis, by country, 2020-2027

    • 7.5 Transcriptomics

      • 7.5.1 Definition, key trends, growth factors, and opportunities

      • 7.5.2 Market size analysis, by region, 2020-2027

      • 7.5.3 Market share analysis, by country, 2020-2027

    • 7.6 Metabolomics

      • 7.6.1 Definition, key trends, growth factors, and opportunities

      • 7.6.2 Market size analysis, by region, 2020-2027

      • 7.6.3 Market share analysis, by country, 2020-2027

    • 7.7 Other Applications

      • 7.7.1 Definition, key trends, growth factors, and opportunities

      • 7.7.2 Market size analysis, by region, 2020-2027

      • 7.7.3 Market share analysis, by country, 2020-2027

    • 7.8 Research Dive Exclusive Insights

      • 7.8.1 Market attractiveness

      • 7.8.2 Competition heatmap

  • 8. Bioinformatics Services Market,

    • 8.1. Overview

    • 8.2 Academic Institutes & Research Centers

      • 8.2.1 Definition, key trends, growth factors, and opportunities

      • 8.2.2 Market size analysis, by region, 2020-2027

      • 8.2.3 Market share analysis, by country, 2020-2027

    • 8.3 Hospitals & Clinics

      • 8.3.1 Definition, key trends, growth factors, and opportunities

      • 8.3.2 Market size analysis, by region, 2020-2027

      • 8.3.3 Market share analysis, by country, 2020-2027

    • 8.4 Pharmaceutical & Biotechnology Companies

      • 8.4.1 Definition, key trends, growth factors, and opportunities

      • 8.4.2 Market size analysis, by region, 2020-2027

      • 8.4.3 Market share analysis, by country, 2020-2027

    • 8.5 Other End Users

      • 8.5.1 Definition, key trends, growth factors, and opportunities

      • 8.5.2 Market size analysis, by region, 2020-2027

      • 8.5.3 Market share analysis, by country, 2020-2027

    • 8.6 Research Dive Exclusive Insights

      • 8.6.1 Market attractiveness

      • 8.6.2 Competition heatmap

  • 9. Bioinformatics Services Market, By Region

    • 9.1 North America

      • 9.1.1 U.S

        • 9.1.1.1 Market size analysis, By Infections, 2020-2027

        • 9.1.1.2 Market size analysis, By Testing Type, 2020-2027

        • 9.1.1.3 Market size analysis, By Resorbability, 2020-2027

        • 9.1.1.4 Market size analysis, , 2020-2027

      • 9.1.2 Canada

        • 9.1.2.1 Market size analysis, By Infections, 2020-2027

        • 9.1.2.2 Market size analysis, By Testing Type, 2020-2027

        • 9.1.2.3 Market size analysis, By Resorbability, 2020-2027

        • 9.1.2.4 Market size analysis, , 2020-2027

      • 9.1.3 Mexico

        • 9.1.3.1 Market size analysis, By Infections, 2020-2027

        • 9.1.3.2 Market size analysis, By Testing Type, 2020-2027

        • 9.1.3.3 Market size analysis, By Resorbability, 2020-2027

        • 9.1.3.4 Market size analysis, , 2020-2027

      • 9.1.4 Research Dive Exclusive Insights

        • 9.1.4.1 Market attractiveness

        • 9.1.4.2 Competition heatmap

    • 9.2 Europe

      • 9.2.1 Germany

        • 9.2.1.1 Market size analysis, By Infections, 2020-2027

        • 9.2.1.2 Market size analysis, By Testing Type, 2020-2027

        • 9.2.1.3 Market size analysis, By Resorbability, 2020-2027

        • 9.2.1.4 Market size analysis, , 2020-2027

      • 9.2.2 UK

        • 9.2.2.1 Market size analysis, By Infections, 2020-2027

        • 9.2.2.2 Market size analysis, By Testing Type, 2020-2027

        • 9.2.2.3 Market size analysis, By Resorbability, 2020-2027

        • 9.2.2.4 Market size analysis, , 2020-2027

      • 9.2.3 France

        • 9.2.3.1 Market size analysis, By Infections, 2020-2027

        • 9.2.3.2 Market size analysis, By Testing Type, 2020-2027

        • 9.2.3.3 Market size analysis, By Resorbability, 2020-2027

        • 9.2.3.4 Market size analysis, , 2020-2027

      • 9.2.4 Spain

        • 9.2.4.1 Market size analysis, By Infections, 2020-2027

        • 9.2.4.2 Market size analysis, By Testing Type, 2020-2027

        • 9.2.4.3 Market size analysis, By Resorbability, 2020-2027

        • 9.2.4.4 Market size analysis, , 2020-2027

      • 9.2.5 Italy

        • 9.2.5.1 Market size analysis, By Infections, 2020-2027

        • 9.2.5.2 Market size analysis, By Testing Type, 2020-2027

        • 9.2.5.3 Market size analysis, By Resorbability, 2020-2027

        • 9.2.5.4 Market size analysis, , 2020-2027

      • 9.2.6 Rest of Europe

        • 9.2.6.1 Market size analysis, By Infections, 2020-2027

        • 9.2.6.2 Market size analysis, By Testing Type, 2020-2027

        • 9.2.6.3 Market size analysis, By Resorbability, 2020-2027

        • 9.2.6.4 Market size analysis, , 2020-2027

      • 9.2.7 Research Dive Exclusive Insights

        • 9.2.7.1 Market attractiveness

        • 9.2.7.2 Competition heatmap

    • 9.3 Asia-Pacific

      • 9.3.1 China

        • 9.3.1.1 Market size analysis, By Infections, 2020-2027

        • 9.3.1.2 Market size analysis, By Testing Type, 2020-2027

        • 9.3.1.3 Market size analysis, By Resorbability, 2020-2027

        • 9.3.1.4 Market size analysis, , 2020-2027

      • 9.3.2 Japan

        • 9.3.2.1 Market size analysis, By Infections, 2020-2027

        • 9.3.2.2 Market size analysis, By Testing Type, 2020-2027

        • 9.3.2.3 Market size analysis, By Resorbability, 2020-2027

        • 9.3.2.4 Market size analysis, , 2020-2027

      • 9.3.3 India

        • 9.3.3.1 Market size analysis, By Infections, 2020-2027

        • 9.3.3.2 Market size analysis, By Testing Type, 2020-2027

        • 9.3.3.3 Market size analysis, By Resorbability, 2020-2027

        • 9.3.3.4 Market size analysis, , 2020-2027

      • 9.3.4 Australia

        • 9.3.4.1 Market size analysis, By Infections, 2020-2027

        • 9.3.4.2 Market size analysis, By Testing Type, 2020-2027

        • 9.3.4.3 Market size analysis, By Resorbability, 2020-2027

        • 9.3.4.4 Market size analysis, , 2020-2027

      • 9.3.5 South Korea

        • 9.3.5.1 Market size analysis, By Infections, 2020-2027

        • 9.3.5.2 Market size analysis, By Testing Type, 2020-2027

        • 9.3.5.3 Market size analysis, By Resorbability, 2020-2027

        • 9.3.5.4 Market size analysis, , 2020-2027

      • 9.3.6 Rest of Asia-Pacific

        • 9.3.6.1 Market size analysis, By Infections, 2020-2027

        • 9.3.6.2 Market size analysis, By Testing Type, 2020-2027

        • 9.3.6.3 Market size analysis, By Resorbability, 2020-2027

        • 9.3.6.4 Market size analysis, , 2020-2027

      • 9.3.7 Research Dive Exclusive Insights

        • 9.3.7.1 Market attractiveness

        • 9.3.7.2 Competition heatmap

    • 9.4 LAMEA

      • 9.4.1 Brazil

        • 9.4.1.1 Market size analysis, By Infections, 2020-2027

        • 9.4.1.2 Market size analysis, By Testing Type, 2020-2027

        • 9.4.1.3 Market size analysis, By Resorbability, 2020-2027

        • 9.4.1.4 Market size analysis, , 2020-2027

      • 9.4.2 Saudi Arabia

        • 9.4.2.1 Market size analysis, By Infections, 2020-2027

        • 9.4.2.2 Market size analysis, By Testing Type, 2020-2027

        • 9.4.2.3 Market size analysis, By Resorbability, 2020-2027

        • 9.4.2.4 Market size analysis, , 2020-2027

      • 9.4.3 UAE

        • 9.4.3.1 Market size analysis, By Infections, 2020-2027

        • 9.4.3.2 Market size analysis, By Testing Type, 2020-2027

        • 9.4.3.3 Market size analysis, By Resorbability, 2020-2027

        • 9.4.3.4 Market size analysis, , 2020-2027

      • 9.4.4 South Africa

        • 9.4.4.1 Market size analysis, By Infections, 2020-2027

        • 9.4.4.2 Market size analysis, By Testing Type, 2020-2027

        • 9.4.4.3 Market size analysis, By Resorbability, 2020-2027

        • 9.4.4.4 Market size analysis, , 2020-2027

      • 9.4.5 Rest of LAMEA

        • 9.4.5.1 Market size analysis, By Infections, 2020-2027

        • 9.4.5.2 Market size analysis, By Testing Type, 2020-2027

        • 9.4.5.3 Market size analysis, By Resorbability, 2020-2027

        • 9.4.5.4 Market size analysis, , 2020-2027

      • 9.4.6 Research Dive Exclusive Insights

        • 9.4.6.1 Market attractiveness

        • 9.4.6.2 Competition heatmap

  • 10. Competitive Landscape

    • 10.1 Top winning strategies, 2020-2027

      • 10.1.1 By strategy

      • 10.1.2 By year

    • 10.2 Strategic overview

    • 10.3 Market share analysis, 2020-2027

  • 11. Company Profiles

    • 11.1 Illumina

      • 11.1.1 Overview

      • 11.1.2 Business segments

      • 11.1.3 Product portfolio

      • 11.1.4 Financial performance

      • 11.1.5 Recent developments

      • 11.1.6 SWOT analysis

    • 11.2 Thermo Fisher Scientific

      • 11.2.1 Overview

      • 11.2.2 Business segments

      • 11.2.3 Product portfolio

      • 11.2.4 Financial performance

      • 11.2.5 Recent developments

      • 11.2.6 SWOT analysis

    • 11.3 Eurofins Scientific

      • 11.3.1 Overview

      • 11.3.2 Business segments

      • 11.3.3 Product portfolio

      • 11.3.4 Financial performance

      • 11.3.5 Recent developments

      • 11.3.6 SWOT analysis

    • 11.4 BGI

      • 11.4.1 Overview

      • 11.4.2 Business segments

      • 11.4.3 Product portfolio

      • 11.4.4 Financial performance

      • 11.4.5 Recent developments

      • 11.4.6 SWOT analysis

    • 11.5 NeoGenomics

      • 11.5.1 Overview

      • 11.5.2 Business segments

      • 11.5.3 Product portfolio

      • 11.5.4 Financial performance

      • 11.5.5 Recent developments

      • 11.5.6 SWOT analysis

    • 11.6 PerkinElmer

      • 11.6.1 Overview

      • 11.6.2 Business segments

      • 11.6.3 Product portfolio

      • 11.6.4 Financial performance

      • 11.6.5 Recent developments

      • 11.6.6 SWOT analysis

    • 11.7 CD Genomics

      • 11.7.1 Overview

      • 11.7.2 Business segments

      • 11.7.3 Product portfolio

      • 11.7.4 Financial performance

      • 11.7.5 Recent developments

      • 11.7.6 SWOT analysis

    • 11.8 Macrogen

      • 11.8.1 Overview

      • 11.8.2 Business segments

      • 11.8.3 Product portfolio

      • 11.8.4 Financial performance

      • 11.8.5 Recent developments

      • 11.8.6 SWOT analysis

    • 11.9 QIAGEN

      • 11.9.1 Overview

      • 11.9.2 Business segments

      • 11.9.3 Product portfolio

      • 11.9.4 Financial performance

      • 11.9.5 Recent developments

      • 11.9.6 SWOT analysis

    • 11.10 GENEWIZ

      • 11.10.1 Overview

      • 11.10.2 Business segments

      • 11.10.3 Product portfolio

      • 11.10.4 Financial performance

      • 11.10.5 Recent developments

      • 11.10.6 SWOT analysis

    • 11.11 Source BioScience

      • 11.11.1 Overview

      • 11.11.2 Business segments

      • 11.11.3 Product portfolio

      • 11.11.4 Financial performance

      • 11.11.5 Recent developments

      • 11.11.6 SWOT analysis

    • 11.12 Microsynth

      • 11.12.1 Overview

      • 11.12.2 Business segments

      • 11.12.3 Product portfolio

      • 11.12.4 Financial performance

      • 11.12.5 Recent developments

      • 11.12.6 SWOT analysis

    • 11.13 MedGenome

      • 11.13.1 Overview

      • 11.13.2 Business segments

      • 11.13.3 Product portfolio

      • 11.13.4 Financial performance

      • 11.13.5 Recent developments

      • 11.13.6 SWOT analysis

    • 11.14 Fios Genomics

      • 11.14.1 Overview

      • 11.14.2 Business segments

      • 11.14.3 Product portfolio

      • 11.14.4 Financial performance

      • 11.14.5 Recent developments

      • 11.14.6 SWOT analysis

    • 11.15 BaseClear

      • 11.15.1 Overview

      • 11.15.2 Business segments

      • 11.15.3 Product portfolio

      • 11.15.4 Financial performance

      • 11.15.5 Recent developments

      • 11.15.6 SWOT analysis

Purchase Options

Personalize this research

  • Triangulate with your own data
  • Request your format and definition
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed